GLP-1 receptor agonists bring a range of benefits for people managing type 2 diabetes alongside chronic kidney disease (CKD)
Since the mean/median duration for each of these studies was 100,000 patients prescribed a GLP-1RA, after propensity matching, there was reduced risk for PDAC during a 5-year observation period for GLP-1RA users compared to six categories of commonly used diabetes medication classes 44
Pathway key points: GLP-1RA therapy is used within a defined preconception optimization window
Praglutide Gets Orphan Drug Designation for Short Bowel Syndrome [Online] [cited 2023 Jul 21]
This document provides detailed information about a specific batch of a chemical, confirming its identity, purity, and potency
Your own fat tissue is making them for free, while you sleep